Table 2.
Cases | MST | Log-rank | Wilcoxon | Cox’s hazard regression | |||
---|---|---|---|---|---|---|---|
Hazard ratio | 95 % CI | P value | |||||
A. Overall survival | |||||||
WT1 | |||||||
Y | 207 | 16.1 | 0.682 | 0.444 | 1.179 | 0.795–1.808 | 0.422 |
N | 48 | 18.3 | |||||
MUC1 | |||||||
Y | 227 | 16.3 | 0.208 | 0.400 | 1.394 | 0.175–2.374 | 0.175 |
N | 28 | 18.8 | |||||
Erythema | |||||||
≥3 cm | 107 | 17.2 | 0.022* | 0.120 | 0.685 | 0.497–0.938 | 0.018* |
<3 cm | 145 | 16.1 | |||||
Radiation during vaccine | |||||||
Y | 12 | 16.3 | 0.543 | 0.676 | 0.928 | 0.412–1.808 | 0.840 |
N | 243 | 16.5 | |||||
B. Survival from first vaccine | |||||||
WT1 | |||||||
Y | 207 | 9.2 | 0.987 | 0.654 | 1.082 | 0.731–1.658 | 0.701 |
N | 48 | 13.8 | |||||
MUC1 | |||||||
Y | 227 | 9.2 | 0.159 | 0.259 | 1.467 | 0.914–2.504 | 0.116 |
N | 28 | 13.9 | |||||
Erythema | |||||||
>3 cm | 107 | 10.4 | 0.016* | 0.120 | 0.659 | 0.478–0.901 | 0.009* |
<3 cm | 145 | 9.2 | |||||
Radiation during vaccine | |||||||
Y | 12 | 7.4 | 0.595 | 0.529 | 1.445 | 0.645–2.793 | 0.343 |
N | 243 | 10.2 |
* Statistically significant